It’s a very different world now in cancer,” said longtime patient advocate Ginny Mason. “Now you need to understand the ...

Dr. Rainer Storb began studying bone marrow transplantation when the field was in its infancy. As he retires 60 years later, ...

See the latest reports from the Hutchinson Institute for Cancer Outcomes Research (HICOR).

Thomas Legacy Society members feel deeply that cancer and infectious disease must be stopped. They are devoted to inspiring our world-renowned scientists and powering the groundbreaking research that ...

Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

A study published in Nature shows that certain autoantibodies may influence how cancer patients respond to immunotherapy. Autoantibodies are proteins produced by the immune system and have typically ...

In 2024, Obliteride raised more than $9 million for research at Fred Hutch, contributing to more than $58 million raised since 2013. These funds have fueled urgently needed advances in cancer ...

Ten Washington state health organizations recently received grants of up to $15,000 from Fred Hutch Cancer Center’s Community Grants Program. These grants, administered by the Office of Community ...

You are invited to the 3rd Annual BACPAC Prostate Cancer Community Research Symposium, a free event hosted by Fred Hutch Cancer Center and UW Medicine, in collaboration with the Black and ...

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

Innovators Network (IN) is a community of next-generation doers committed to funding cutting-edge research to end cancer and related diseases in their lifetime.

A Fred Hutch Cancer Center outpatient complex serving more than 60,000 adult patients per year will be renamed the Sloan Clinic in recognition of Stuart and Molly Sloan, who have increased their total ...